Sorting of ubiquitinated membrane proteins into lumenal vesicles of multivesicular bodies is mediated by the Endosomal Sorting Complex Required for Transport (ESCRT) apparatus and accessory proteins such as Bro1, which recruits the deubiquitinating enzyme Doa4 to remove ubiquitin from cargo. Here we propose that Bro1 works as a receptor for the selective sorting of ubiquitinated cargos. We found synthetic genetic interactions between BRO1 and ESCRT-0, suggesting that Bro1 functions similarly to ESCRT-0. Multiple structural approaches demonstrated that Bro1 binds ubiquitin via the N-terminal trihelical arm of its middle V domain. Mutants of Bro1 that lack the ability to bind Ub were dramatically impaired in their ability to sort Ub-cargo membrane proteins, but only when combined with hypomorphic alleles of ESCRT-0. These data suggest that Bro1 and other Bro1 family members function in parallel with ESCRT-0 to recognize and sort Ub-cargos.
INTRODUCTION
Ubiquitin (Ub) is a sorting determinant mediating the degradation of a wide variety of membrane proteins in lysosomes by sorting them into the intralumenal vesicles (ILVs) of multivesicular endosomes/bodies (MVBs) (Hanson and Cashikar, 2012) . Ub is recognized by the ESCRT (Endosomal Sorting Complex Required for Transport) apparatus, which couples cargo recognition and sorting with the formation and scission of intralumenal vesicles (Henne et al., 2011) . Recognition of ubiquitinated cargo (Ub-cargo) occurs early during ILV formation and is mediated in large part by ESCRT-0 and ESCRT-I, which each have multiple Ub-binding domains (UBDs) (Clague et al., 2012; Shields and Piper, 2011) . ESCRT-0, composed of Vps27 and Hse1 in yeast and by Hrs and STAM1/2 in humans, binds Ub via multiple UBDs housed within its Vps27/Hrs/Stam (VHS) and Ubiquitin Interacting Motif domains. ESCRT-0 is thought to be the endosomal Ub-sorting receptor that initiates cargo capture and has a variety of protein interactions that equip it for this task. Direct binding to clathrin positions it within clathrin-enriched endosomal subdomains where cargo is segregated for recycling or degradation. ESCRT-0 also binds ESCRT-I to facilitate assembly of the ESCRT apparatus and the transfer of Ub-cargo to ESCRT-I and -II. ESCRT-0 also associates with both Ub ligases and deubiquitinating enzymes (DUbs) that may alter cargo ubiquitination and regulate its sorting into the MVB pathway. Several other proteins are proposed to work in parallel to ESCRT-0 as alternative ESCRT-0-like Ub-sorting receptors (Clague et al., 2012; Shields and Piper, 2011) . Among these are the Tom1:Tollip complex and GGA3. Like the two subunits of ESCRT-0, both Tom1 and GGA3 have VHS domains and bind clathrin, ESCRT-I, and Ub. Functional studies implicate these as endosomal Ub-sorting receptors, although their site(s) of action and the repertoire of cargo substrates have yet to be clarified.
Late in the sorting process, ILVs are separated from the limiting membrane of the endosome by ESCRT-III, a heteropolymeric assembly of subunits centered on Snf7/CHMP4 (Babst et al., 2011) . Yeast Snf7 also binds to Bro1, which in turn recruits the DUb Doa4 to remove Ub from cargo prior to its entry into ILVs (Kim et al., 2005; Luhtala and Odorizzi, 2004; Richter et al., 2007) . Loss of Doa4 causes Ub to hyperaccumulate in the vacuole lumen and be depleted from the cytosol (Amerik et al., 2000; Ren et al., 2008) . The Bro1:Doa4 complex is thought to work late in the sorting process, since earlier removal of Ub would permit cargo to escape incorporation into ILVs. However, loss of Bro1 produces a phenotype similar to loss of ESCRTs, while loss of Doa4 does not, demonstrating that Bro1 provides functions beyond the recruitment of Doa4 (Odorizzi et al., 2003; Raymond et al., 1992; Springael et al., 2002) . Bro1 belongs to a larger family of related proteins, including mammalian Alix and HD-PTP, which share a common architecture, bind ESCRT-I, and have both an N-terminal Bro1 homology domain that binds the ESCRT-III subunit Snf7/CHMP4 and a middle V domain that, in the case of Alix, binds YPxL peptide motifs (Fisher et al., 2007; Kim et al., 2005; Lee et al., 2007) . YPxL binding enables Alix to sort YPxL-bearing cargos into MVBs and to mediate ESCRT-dependent budding of viruses that have Gag proteins bearing YPxL motifs (Baietti et al., 2012; Dores et al., 2012; Doyotte et al., 2008; Odorizzi, 2006; Sadoul, 2006; Strack et al., 2003) . These data suggest that Alix and other Bro1-family proteins might recruit cargo to the ESCRT apparatus, at least along a Ub-independent pathway. Although a clear role for these proteins in the canonical sorting of Ub-cargo has not been established, recent studies have demonstrated that Alix can bind Ub, thus supporting this possibility (Joshi et al., 2008; Keren-Kaplan et al., 2013; Sangsuriya et al., 2010; Dowlatshahi et al., 2012) .
Here we propose that Bro1 works in parallel with ESCRT-0 and contributes to the recognition and sorting of Ub-cargo into the MVB pathway. We show that deficiencies in Bro1 and ESCRT-0 yield synthetic phenotypes and that, like ESCRT-0, Bro1 binds clathrin. We show that the V domains of multiple Bro1 family members bind Ub and that mutations compromising Ub binding result in defective sorting of Ub-cargo.
RESULTS
Bro1 and the ESCRT-0 Ub-Sorting Receptor Interact Genetically Deletion of either Vps27 or Hse1, two ESCRT-0 subunits (orthologous to Hrs and Stam1/2 in mammalian cells), causes a strong ''class E'' Vps phenotype characterized by secretion of vacuolar proteases, accumulation of large late endosomal structures, and the inability to sort ubiquitinated membrane proteins into the vacuolar lumen via the MVB pathway (Bilodeau et al., 2002 ). This phenotype is observed when HSE1 is deleted from the SF838-9D parental strain but not when deleted from the SEY6210 parental strain ( Figure 1A ), as also noted in previous studies (Stringer and Piper, 2011) . Diploid cells generated from these two hse1D strains also showed no sorting defects, providing us with a genetic tool for identifying genes that function in parallel with ESCRT-0 and whose depletion exacerbates the consequences of HSE1 loss. The homozygous hse1D diploid was sporulated, and after one backcross to SEY6210 hse1D cells, we found that the phenotype of defective MVB sorting segregated 2:2 (Figure S1A available online). We determined the genomic sequence of the SEY6210 hse1D strain and compared it to that of hse1D segregants from a second and third backcross that showed MVB sorting defects to identify a single base-pair change in BRO1 (resulting in a C359Y change) that was present in defective progeny but not in the parental SEY6210 hse1D strain. Sanger sequencing confirmed this difference ( Figure 1B) .
Residue 359 of Bro1 lies within the linker region between the N-terminal Bro1 homology domain and the middle V domain. Importantly, the SF838-9D parental strain has normal MVB and vacuolar protease sorting pathways despite having the BRO1 Y359 allele. However, a bro1D deletion has a typical ''class E'' Vps phenotype (Raymond et al., 1992) , indicating that a sorting defect results only when the Y359-encoding allele of BRO1 is combined with loss of HSE1. As confirmation, we made homozygous hse1D diploids from SF838-9D and SEY6210, in which the BRO1 gene was knocked out of either haplotype. The hse1D diploids having only the Y359 Bro1 from SF838-9D showed a strong MVB sorting defect as assessed by the localization of Sna3-GFP ( Figure 1C ), a well-characterized MVB cargo (Macdonald et al., 2012b) . In contrast, hse1D homozygotes with the SEY6210 allele of BRO1 (C359) sorted Sna3-GFP normally. Although the biochemical defects of the Y359 Bro1 mutant were not investigated, the value of this mutant was to help uncover the genetic interaction between Bro1 and ESCRT-0.
To confirm the synthetic genetic interaction between Bro1 and Hse1, we analyzed MVB sorting in SEY6210 bro1D cells that also contained defined mutations in ESCRT-0 ( Figure 1D ). Loss of Bro1 blocked the delivery of Ste3-GFP to the vacuole lumen, causing these cells to accumulate large ''class E'' endosomal compartments. Interestingly, other cargoes could still be sorted to the vacuole of bro1D cells, albeit to a limited degree. Both Ste3-GFP-Ub (an in-fame fusion of Ub on to Ste3-GFP) and GFP-tagged Mup1 (a methionine transporter) were sorted moderately well in bro1D cells and normally in hse1D cells. Combined loss of HSE1 and BRO1 caused substantial sorting defects that were observed by microscopy ( Figure 1D ) and by immunoblotting for a GFP fragment ( Figure S1B ), which is cleaved from cargo upon delivery into the vacuolar lumen (Hettema et al., 2004) . A synthetic defect was also observed when the bro1D mutation was combined with a hypomorphic mutation in Vps27 that blocks the ability of ESCRT-0 to bind to clathrin (vps27 Dchc1 ) (Bilodeau et al., 2003; Shields et al., 2009 ). Finally, we found that levels of Bro1 were unperturbed by alterations in ESCRT-0 and that levels of ESCRT-0 subunit Vps27 were unperturbed by changes in BRO1 or HSE1, indicating that the synthetic interaction between Bro1 and ESCRT-0 functions is specific ( Figure S1C ).
Bro1 Acts Early in Cargo Sorting and Binds Clathrin
The synthetic genetic interaction between Bro1 and ESCRT-0 suggested that Bro1 may act early in the MVB sorting process in parallel with ESCRT-0. This function would be distinct from that previously established for Bro1, which is to recruit the Doa4 DUb to ESCRT-III to remove Ub from MVB cargo and rescue Ub from excessive vacuolar degradation and which is mediated by Bro1 binding to Snf7 via its N-terminal Bro1 domain and Doa4 via its proline-rich C-terminal domain (Amerik et al., 2006; Nikko and André , 2007; Richter et al., 2007) . Previous studies show that fusing the catalytic domain of a DUb onto ESCRT-0 effectively deubiquitinates cargo ''early'' in the sorting process, thereby blocking delivery to the vacuolar lumen (MacDonald et al., 2012a; Stringer and Piper, 2011) . This block can be circumvented by translationally fusing Ub to the C termini of cargo, making it resistant to the effects of ESCRT-DUb fusions. We reasoned that if Bro1 also could intervene early in the sorting process in parallel to ESCRT-0, then a Bro1-DUb fusion protein should also block cargo sorting to the vacuole and not merely replace the Bro1:Doa4 complex thought to work postsorting to simply recycle Ub. Fusions of Bro1 to the catalytic domain of Ubp7 or UL36 (a yeast cysteine-based Ubspecific protease or a DUb found within the tegument protein of herpes simplex virus-1, respectively) were expressed in wild-type cells (Figure 2A ). In addition to causing defective sorting of Ste3 and Sna3, Bro1-Ubp7 and Bro1-UL36 also perturbed sorting of Gap1 and Fur4 (the general amino acid permease and uracil permease). In contrast, Ste3-GFP-Ub, containing an inframe fusion of Ub that cannot be removed by DUbs, sorted normally, demonstrating that Bro1-Ubp7 and Bro1-UL36 exert their inhibitory effect at the level of deubiquitinating cargo rather than altering the function of ESCRT apparatus itself. Mup1-GFP was only modestly affected by the Bro1-DUb fusions ( Figure 2A) and also underwent some level of MVB sorting, even in the absence See also Figure S1 and Tables S1 and S2. of Bro1 ( Figure 1D ), suggesting that Bro1 may normally operate on a subset of MVB cargos. The effect of Bro1-DUb in blocking cargo sorting is not due simply to recruiting DUb activity to ESCRT-III. We found that expressing a fusion of UL36 to the Microtubule Interacting and Trafficking (MIT) domain of Vps4, which interacts with MIT-Interaction Motifs within ESCRT-III subunits (Obita et al., 2007; Stuchell-Brereton et al., 2007) , did not affect MVB cargo sorting ( Figure 2B ). However, MIT-UL36 as well as UL36 fusion to full-length Bro1 and just the N-terminal Bro1 domain prevented the delivery of GFP-Ub into the vacuole, demonstrating that these proteins could stimulate recycling of Ub from cargo before it was consumed in the MVB sorting process. Thus, the dominant effect of Bro1-DUb proteins on the sorting of particular cargos likely reflects a function of Bro1 that works early in the cargo sorting process ( Figure 2C) .
One of the biochemical features of ESCRT-0 and other proposed ESCRT-0-like Ub-sorting receptors such as Tom1 and (legend continued on next page)
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Bro1 as a Ubiquitin-Sorting Receptor GGAs is that they bind clathrin, which is found in distinct endosomal subdomains that concentrate Ub-cargo and help localize ESCRT-0 (Shields and Piper, 2011) . Coimmunoprecipitation experiments showed that Bro1 shares the ability of ESCRT-0 to associate with clathrin in vivo ( Figure 2D ). Clathrin-binding activity was housed within the middle Bro1 V domain since a glutathione S-transferase (GST)-V domain fusion protein was sufficient to pull down clathrin from yeast lysates ( Figure 2E ). Also, the recombinant N-terminal b-propeller domain of clathrin heavy chain could specifically bind GST-V, indicating that the Bro1 V domain binds directly to clathrin ( Figure 2E ). Interestingly, Bro1 has a conserved clathrin binding box motif (ter Haar et al., 2000) within an unstructured loop at the vertex of its V domain ( Figures S2A and S2B ). However, mutations in this region did not block coimmunoprecipitation of Bro1 with clathrin from cell lysates, suggesting that other motifs may also be sufficient for clathrin association (data not shown).
The V Domains of Bro1 Family Proteins Bind Ub
One of the key features of ESCRT-0 that allows it to act as a sorting receptor for Ub-cargo is its ability to bind Ub. Recently, the Bro1 homolog Alix was found to bind Ub via its middle V domain (Joshi et al., 2008) . The Alix V domain is organized into two trihelical bundles adopting the shape of a V with a short and long arm (Fisher et al., 2007; Lee et al., 2007) . We found that the V domains of Bro1, Rim20, human Alix, and HD-PTP bind directly to Ub even though they share only a moderate level of sequence identity. This was demonstrated by the ability of recombinant V domains to bind a Ub-GST fusion protein ( Figure 3A ) and to bind K63-linked polyubiquitin (poly-Ub) chains ( Figure 3B ). Chemical shift perturbations measured by nuclear magnetic resonance (NMR) heteronuclear single quantum coherence (HSQC) experiments with 15 N-Ub showed that the Bro1 V domain bound mono-Ub ( Figures 3C, S3A , and S3B) and used a binding surface centered on the hydrophobic patch of Ub that comprised I44, V70, L8, and R42 ( Figure 3D ), which serves as a common surface engaged by the vast majority of Ub-binding proteins (Husnjak and Dikic, 2012) . These experiments utilized the V domain from S. castelli Bro1, which shares 56% identity with S. cerevisiae Bro1 V but had better stability in vitro. The Alix V domain also bound mono-Ub through the same general surface patch, although the profile of chemical shift perturbations in 15 N-Ub induced by Alix V binding was slightly different, indicating a different binding mode ( Figure 3D ; Figures S3A and S3B). Significant line broadening was evident for all peaks of 15 N-Ub with increasing concentrations of V domains ( Figure S3C ). This was most severe for His-domain protein tyrosine phosphatase (HD-PTP) V domain, which precluded the ability to use chemical shift changes to map the interface on Ub. The NMR peaks from Ub bound to V domain were likely broadened because the Ub-V complex is much larger than Ub alone and in range of intermediate exchange on the NMR timescale. Using loss of peak intensity as a measure of binding estimates the dissociation constant, K D , of the V domains of Alix and HD-PTP in the range of 50 mM and the S. castelli Bro1 V domain 5 times higher.
To map the major Ub-binding site on Bro1 V in solution, we performed a series of paramagnetic relaxation enhancement (PRE) experiments using a set of Bro1 V mutants containing a nitroxide spin label (methanethiosulfonate [MTSL]) attached to cysteine residues substituted at different positions ( Figure 3E ). MTSL-labeled Bro1 V proteins were used in HSQC experiments with 15 N-Ub in the presence and absence of ascorbate. The oxidized form of the attached MTSL enhances the relaxation rate of nearby spin systems, resulting in a loss of peak intensity in HSQC spectra as compared to the ascorbate-reduced form that has lost its unpaired electron (Iwahara and Clore, 2006) . Significant PRE effects on any of the residues of 15 N-Ub were plotted for each of the labeled Bro1 V variants ( Figure 3F ), revealing dramatic effects for spin labels incorporated in the N-terminal helix of first trihelical arm of the Bro1 V domain at residues 381 and 392. As confirmation, we generated a ''half-V'' protein that comprised only the first trihelical arm and found that it bound Ub in GST pull-down assays and induced a profile of chemical shift perturbations on the surface 15 N-Ub similar to that of full-length Bro1 V ( Figures S3D-S3I ).
Further structural information about Ub binding was obtained through protein crystallography experiments yielding a structure of Ub bound to the first trihelical arm the S. castelli Bro1 V domain. This structure was solved from crystals containing a selenomethionine-labeled Bro1V:Ub A28M complex diffracting to 3.6 Å that allowed us to use the single-wavelength anomalous dispersion method to obtain experimental phases (Table 1) . Two V domains were found in the asymmetric unit with five selenium sites per molecule of V domain. Despite the low level of sequence homology, the Bro1 V domain was remarkably similar to the Alix V domain, each with two trihelical arms with the protein sequence crisscrossing between the two arms. Unlike Alix V, the two arms of Bro1 V were of similar size ( Figure 4A ), and the relative orientation of the trihelical arms and the helices within the distal C-terminal arm as they twist through the arm were different.
Ub was bound to one of the V domains (Chain A) within the asymmetric unit ( Figures 4B, S4A , and S4B), where it was positioned along residues 375-386 of the exposed inner surface of the N-terminal trihelical bundle, in direct agreement with the PRE experiments placing residue 381 near the major site of Ub binding in solution. Ub was oriented along the N-terminal V domain helix so that the C terminus of Ub was near the opening of the V domain and the N terminus of Ub was pointing toward the vertex of the V domain. The binding surface in Ub that was identified by chemical shift perturbations in NMR HSQC experiments (including residues L8, I44, and V70) was oriented toward the Bro1 V N-terminal helix ( Figure 4B ). To confirm the See also Figure S2 and Tables S1 and S2 . (legend continued on next page)
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Bro1 as a Ubiquitin-Sorting Receptor low-resolution crystal structure, we made an additional spinlabeled Bro1 V domain with MTSL attached to the first residue of the V domain (residue 369) and compared its PRE profile on 15 N-Ub to a Bro1 V domain spin labeled at residue 392. The differential PRE effect between these two site-specific spin labels on the backbone amides of Ub showed that residue 369 of Bro1 V was nearer to the C terminus of Ub, while 381 was nearer to the N-terminal region of Ub ( Figure S4C ). Together, these data demonstrate that Ub lies along the first alpha helix of the Bro1 V domain in an antiparallel orientation and indicate that I377 likely participates in hydrophobic interactions with L8, I44, and V70 of Ub.
V Domains Adopt an Open Conformation in Solution
The structure of Bro1 V (Figure 4 ) and previous structures of Alix V domains show a relatively closed conformation that might restrict access of some YPxL-containing proteins or ubiquitinated proteins to their binding sites on the inner surface (Fisher et al., 2007; Lee et al., 2007) . Indeed, full-length Alix forms an intramolecular interaction (between its C-terminal proline-rich domain and its N-terminal Bro1 homology domain), which diminishes binding to YPxL-containing proteins. This interaction may function as a clasp, holding the V domain in a closed conformation that, upon release, allows the V domain to spring open to expose protein interaction sites (Pires et al., 2009; Zhai et al., 2011; Zhou et al., 2010) . We obtained several lines of evidence demonstrating that, in the absence of such a clasp, the V domain adopts an open conformation in solution. Small angle X-ray scattering (SAXS) data from monodisperse Bro1 and Alix V domains were used to generate ab initio envelopes and revealed elongated V domains that were splayed open relative to their crystal structures ( Figures 5A and S5A ). These elongated shapes were consistent with gel filtration data and dynamic light scattering, showing that the monomeric 40 kDa Alix V and the 36 kDa of Bro1 V domains behaved as larger forms ( Figures S5C-S5E ). Attempts to crystallize Alix V in complex with Ub yielded a 6.5 Å crystal structure of Alix V in an open conformation without clear electron density for Ub ( Figure 5C ; Table 1 ). The single wavelength anomalous dispersion technique with isomorphous crystals of seleniomethionine-labeled Alix V allowed us to locate the selenium sites, determine phases, and obtain traceable electron density maps. The features in the electron density maps clearly matched details in other Alix V structures; however, the angle between the two arms of Alix V was far greater (e.g., an open conformation) than that found for the previously determined closed conformations ( Figure 5D ; Movie S1). Having both the open and closed crystal structures of Alix V and the closed structure of Bro1 V allowed us to calculate experimental fit to the SAXS data of isolated V domains in solution. This analysis ( Figure S5B ) showed that the SAXS data best describe a mix of V domains in both open and closed forms at a ratio of roughly 50:50.
The large shape changes displayed by V domains prompted us to test whether they might undergo more dramatic changes in solution involving the swapping of N-and C-terminal helices between the trihelical bundles. We engineered a tobacco etch virus (TEV) protease site in the middle hinge region of the V domain so that, if a swap did occur, the protein could separate into two roughly equal fragments. However, cleaved Bro1 V stayed intact assessed by gel filtration even after extended incubation at 25 C ( Figure S5F ). Together, these data show that, while the overall topology of V domains is retained in solution, they can undergo a variety of conformational changes, with small-scale changes evident in the packing of the helices within Bro1 V crystals ( Figure S4A ) and large-scale changes in a mix of open and closed forms in solution ( Figure 5 ).
Ub Binding by Bro1 Is Required for MVB Sorting of Ub-Cargo
To test the functional relevance of Ub binding by Bro1, we generated mutants of Bro1 V domain specifically defective in binding Ub. A series of mutations within the first trihelical arm were tested for their ability to disrupt Ub binding using PRE experiments with 15 N-Ub and Bro1 V mutants spin labeled at position 381. Although side chains cannot be resolved with the diffraction data in the crystal structure, I377 is predicted from our structural data to be centered under the hydrophobic patch of Ub, whereas L386 lies under a loop region between a2 and b5 of Ub containing residues Q62, K63, E64, and S65. We found that mutation of I377 and/or L386 blocked Ub binding as observed by the loss of PRE effect in 15 N Ub ( Figure 6A ). Loss of Ub binding was also indicated by a loss in chemical shift perturbations in the backbone amides of Ub residues that mediate binding to Bro1 V (Figure 6B ) and by loss of the ability of Bro1 V domains immobilized on beads to bind K63 poly-Ub chains ( Figure 6C ). Compared to the wild-type (WT) Bro1 V protein, the mutant V domains were produced at similar levels, were just as soluble, and had identical NMR proton spectra ( Figure S6 ), indicating that the mutant V domains retained their overall structure.
We next assessed the ability of Bro1 containing Ub-bindingdefective V domains to sort cargo into the MVB pathway (Figure 7) . Here we analyzed chimeric Bro1 proteins in which the V domain of a hemagglutinin (HA)-epitope-tagged Bro1 from S. cerevisiae was substituted with the mutant V domains of S. castelli characterized earlier. The WT chimeric Bro1-HA was HSQC spectra of 30 mM 15 N-Ub with 100 mM of the indicated MTSL-labeled Bro1 V domains were collected in the presence (oxidized) and absence (reduced) of 2 mM ascorbate. Peak intensity ratios of these two spectra were calculated for each backbone amide. Plot of Ub residues that were subject to significant PRE, as reflected by a significant reduction in peak intensity ratio, are defined as >1 SD above the mean for that residue across the whole data set. See also Figure S3 and Table S1 .
produced at levels identical to those of full-length S. cerevisiae Bro1-HA and complemented the MVB sorting defects (Figures 7A and S7 
DISCUSSION
Based on the data presented here and elsewhere, we propose that Bro1 works early in the MVB biogenesis pathway, as a Ub-sorting receptor that functions in parallel with ESCRT-0. This role would be distinct from its later function as a recruitment factor for Doa4, the DUb that works late in the process of MVB biogenesis to recycle Ub from cargo postsorting (Amerik et al., 2006; Richter et al., 2007) . This model is supported by the genetic interactions we observed between ESCRT-0 and Bro1, wherein hypomorphic mutations in both show dramatic synthetic phenotypes. Further support comes from the observation that expressing Bro1-DUb fusion proteins blocks the sorting of cargo into MVBs and from the finding that Bro1 shares several binding partners with ESCRT-0, including Ub, clathrin, ESCRT-I, Ub ligases, and DUbs (Nikko and André , 2007) . These interactions provide a biochemical rationale for how Bro1 can execute an ESCRT-0-like function as a Ub-sorting receptor. We found that the interaction of the Bro1 V domain with Ub was critical for sorting Ub-cargo into MVBs only when ESCRT-0 function was weakened, an observation supporting the idea that Bro1 and ESCRT-0 provide similar overlapping functions. Interestingly, even when Ub-cargo sorting was blocked, other functions such as sorting of the soluble vacuolar hydrolase CPY were normal, demonstrating that the MVB and vacuolar hydrolase sorting functions of Bro1 are separable and that Ub binding contributes to the former. Together, these data suggest that Bro1 belongs to an expanding coterie of endosomal Ub-sorting receptors, thereby diversifying membership beyond ESCRT-0, GGA, and Tom1-related proteins, which have a very similar domain organization (Clague et al., 2012; Shields and Piper, 2011) . It is plausible that each of these Ub receptors directs its attention to specific sets of cargos These crystallography statistics are given for an open conformation of the human Alix V domain (PDB ID: 4JJY) and a crystal structure of the yeast Bro1 V domain in a complex with Ub (PDB ID: 4JIO).
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Bro1 as a Ubiquitin-Sorting Receptor with some level of overlap. This possibility is supported by our findings that loss of Bro1 or mutation of the Ub-binding site in the V domain leads to more dramatic defects in MVB sorting for cargos such as Ste3 than for others such as Mup1. If Bro1 does work as an upstream Ub-sorting receptor in the MVB biogenesis pathway, then the mammalian Bro1 family members Alix and HD-PTP may likewise execute such a function. Correspondingly, Alix was found to bind membrane proteins bearing YPxL motifs and to usher them into endosomal ILVs (Baietti et al., 2012; Dores et al., 2012) . For one of these cargos (Par1), ubiquitination of the cargo itself was not required (although ubiquitination of associated proteins might be), suggesting that Alix can work as a sorting receptor for certain Ubindependent cargos. Since the Alix V domain binds Ub, it is possible that this protein also serves as a receptor for Ubcargos. Unlike the loss of ESCRT-0 or ESCRT-I, loss of Alix in mammalian cells does not dramatically alter endosome See also Figure S4 and Table S1 .
morphology, nor does it block sorting of the few ubiquitinated membrane protein cargos that have been examined (Odorizzi, 2006) . Thus, Alix may handle only a subset of Ub-cargos, or ESCRT-0 could substitute for Alix's absence in experimental contexts. Interestingly, Dictyostelium discoideum does not have a canonical ESCRT-0 (Hrs/STAM) but does express a Bro1 homolog (Dd-Alix) and a Tom1 homolog (Dd-Tom1), the latter of which participates in many of the same protein interactions as a canonical ESCRT-0. Nevertheless, eliminating Dd-Tom1 affects neither the sorting of endosomal ubiquitinated proteins nor the biogenesis of MVBs, suggesting that Dd-Alix instead may provide much of the ESCRT-0-like function in this organism (Blanc et al., 2009 ). Like both Alix and Bro1, HD-PTP also directly binds Ub, ESCRT-I, and ESCRT-III and localizes to endosomes (Doyotte et al., 2008; Miura et al., 2008; Nikko and André , 2007; Stefani et al., 2011; Strack et al., 2003) . Loss of HD-PTP promotes cell migration and is associated with cancer progression (Cao et al., 1998; Castiglioni et al., 2007; Gilbert et al., 2011; Lin et al., 2011) . At the cellular level, RNA interference (RNAi)-mediated depletion of HD-PTP causes morphological changes in endosomes and an accumulation of ubiquitinated proteins on them, a cellular phenotype similar to that resulting from ESCRT-0 depletion (Doyotte et al., 2008) . Although it is not clear what types of Ub-cargo HD-PTP might sort, candidates include EGFR, integrins, and E-cadherin (Castiglioni et al., 2007; Lin et al., 2011; Miura et al., 2008) .
Although we have speculated that other Bro1 family members can behave as endosomal Ub-sorting receptors, their capacity to bind Ub could instead be used for different or additional purposes. For instance, many Ub-binding proteins, including Alix, can themselves undergo ubiquitination and may act as a scaffold for a variety of other Ub-binding proteins involved in endocytosis and/or viral budding (Hoeller and Dikic, 2010; Sette et al., 2010) . In the future, such alternative models can be tested using Ub-binding-defective mutants of other Bro1 family proteins. Predicting how to generate such mutants will be somewhat challenging, however. Although the Ub-binding region we identified is conserved among Bro1 orthologs, how to accurately predict the Ub-binding site in the V domains of other proteins is not obvious. The V domains of HD-PTP, Alix, and Bro1 are only 13%-15% identical, and recent mutagenesis experiments indicate that Alix houses a UBD somewhere within its distal trihelical arm, along a sequence that is only conserved across Alix orthologs (Dowlatshahi et al., 2012; Keren-Kaplan et al., 2013) . This theme of different Ub-binding modes between functional orthologs is found for components of the ESCRT apparatus as well; Vps27 (ESCRT-0), Mvb12 (ESCRT-I), and Vps36 (ESCRT-II) share the ability to bind Ub with their mammalian counterparts Hrs, Mvb12A, UBAP1, and Eap45 but use different binding motifs to do so (Clague et al., 2012; Shields and Piper, 2011) . This is consistent with the fact that low-affinity binding motifs for Ub are often structurally simple, suggesting they may not be that challenging to evolve.
EXPERIMENTAL PROCEDURES
Plasmids and yeast strains used are listed in Tables S1 and S2 . BRO1-expressing plasmids with various V domains were made in low-copy/yeast centromere plasmids encoding the BRO1 promoter and the flanking N-terminal and C-terminal portions of S. cerevisiae Bro1 upstream of two HA epitopes.
V domains produced in E.coli BL21(DE3) were purified over and size exclusion chromatography and cleaved from their 6XHis tag with TEV protease prior to crystallography. Selenomethionine (SeMet)-labeled proteins were expressed using the methionine pathway inhibition procedure (Doublie and Carter, 1992) . Diffraction data were collected on the 4.2.2 beamline at the Advanced Light Source (Berkeley, CA, USA) on crystals containing Ub (A28M to allow labeling with selenium) and Bro1 V (with K417A, K418A, K419A mutations made to reduce surface entropy; Goldschmidt et al., 2007) or crystals of Alix. Data for SeMet-Bro1V:Ub (A28M) were processed using d*TREK (Pflugrath, 1999) and phased with phenix.autosol (Terwilliger et al., 2009 ) using the single-wavelength anomalous dispersion method. Phenix.autobuild and phenix.refine were used to iteratively build and improve the Bro1V Ca-only model. Ub (Protein Data Bank [PDB] ID: 1UBQ) was docked into the clearly visible density near the Bro1V N terminus and refined with all atoms. The diffraction data for SeMet-AlixV:Ub were integrated and scaled using d*TREK and prepared for SHELXD (Sheldrick, 2008) using xprep (Bruker AXS, Madison, WI, USA). Phenix was used to improve the quality of the map sufficiently so that the two arms of AlixV from the high-resolution structures could be independently placed in the electron density and then refined with secondary structure restraints in place. Coot was used to manually fit the structure, and PyMOL was used to generate the structural figures.
SAXS data (collected at the 12-ID-B beamline at the Advanced Photon Source, Argonne National Laboratory, Argonne, IL, USA; and the SIBYLS 12.3.1 beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, CA, USA) were processed with PRIMUS (Konarev et al., 2003) . The radius of gyration (R g ) estimated from Guinier plots was 34.3 Å for Alix V and 35.4 Å for Bro1 V. The maximum diameter (D max ) determined with GNOM was 116.0 Å and 111.1 Å for Alix and Bro1 V domains, respectively. The ab initio models were generated with GASBOR (Svergun et al., 2001 ). Paramagnetic relaxation enhancement effects were measured using cysteine-containing Bro1 proteins labeled with MTSL [(1-oxyl-2,2,5,5-tetramethylpyrroline-3-methyl)-methanethiosulfonate] (Toronto Research Chemicals, Toronto, Ontario, Canada). Incorporation to >90% was validated by electron spin resonance analysis. Peak intensity ratios of 15 N-Ub when bound to the oxidized versus reduced MTSL-labeled Bro1 proteins were calculated to quantify the degree of PRE effects. GFP-fusion proteins were localized in cells grown to mid-log phase at 30 C and imaged as previously described (Bilodeau et al., 2003) . Genes under control of the CUP1 promoter were induced with 50 mM CuCl 2 . Yeast protein extracts for immunoblotting were prepared as described elsewhere (Kushnirov, 2000) . GST pull-down experiments and immunoprecipitations were done as described previously ( See also Figure S5 , Table S1 , and Movie S1. I377R L386R  E380A L386R  I377R E380A  I377R  L386R  L385N L386N  S376A I377A Y378A  Y378A S379A E380A  S379R A383R  Y378R  L385R  S376R   E389A M390A E391A   E394R  M390N E391N  R387E K388E   R564D K567D  L566A K567A E568A  K567A E568A E569A  R572A T573A M574A  K578E  T617A T618A R619A  L605A F606A E607A  E621R  F625R   PRE , 42, 44, 48, 49, 69, 70 , and 71 and setting that value equal to 1 for the WT Bro1 V domain.
E381C only
(C) The WT and mutant recombinant V domains were immobilized on a-V5 polyclonal antibody-coated beads, washed, and incubated with K63-linked polyubiquitin chains. Beads alone or bound to an irrelevant V5-epitoped protein were also included. Beads were washed and immunoblotted with a-V5 or a-Ub monoclonal antibodies. See also Figure S6 and Table S1 .
were subsequently incubated for 1 hr with 2 mg of K63-linked poly-Ub (Boston Biochemicals, Cambridge, MA, USA) in 200 ml PBS containing 0.02% of Triton X-100, 0.1% bovine serum albumin or casein. Beads were washed five times; bound complexes were eluted with Laemmli sample buffer and heating to 70 C for 5 min.
To compare yeast genomic DNA, 7-9 million 75-base-pair, single-end reads were generated for each sample on a HiSeq 2000 platform machine (Illumina, San Diego, CA, USA). Data were analyzed by the University of Washington Genome Sciences group as detailed in the Supplemental Experimental Procedures. Figure S7 and Tables S1 and S2. 
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